TETRA BIO-PHARMA
Dead / Abandoned — Abandoned — failure to respond (as of 09 Jun 2023)
What this means for you
This application is over — abandoned 25 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97392917
- Mark type
- Stylized text
- Filed
- 03 May 2022
- Abandoned
- 25 May 2023
- Attorney of record
- John M. Manion
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations to treat medical conditions, namely, to treat anorexia, anxiety and depression, arthritis, rheumatoid arthritis, chronic pain, fibromyalgia, pain management in oncology, glaucoma, inflammation, insomnia and sleep disorders, Alzheimer's disease, Crohn's disease, nausea and vomiting, weight gain, ulcerative colitis, multiple sclerosis, amyotrophic lateral sclerosis, stress, irritable bowel syndrome, movement disorders, musculoskeletal disorders, Parkinson's disease, epilepsy
- Class 010 — Medical apparatus: Medical devices for administering pharmaceutical preparations, namely, inhalers, masks, pipes, for administering pharmaceutical preparations by inhalation, to treat medical conditions, namely, to treat anorexia, anxiety and depression, arthritis, rheumatoid arthritis, chronic pain, fibromyalgia, pain management in oncology, glaucoma, inflammation, insomnia and sleep disorders, Alzheimer's disease, Crohn's disease, nausea and vomiting, weight gain, ulcerative colitis, multiple sclerosis, amyotrophic lateral sclerosis, stress, irritable bowel syndrome, movement disorders, musculoskeletal disorders, Parkinson's disease, epilepsy
Owner
- TETRA-BIO-PHARMA INC., Orléans, ONTARIO, CA
Prosecution history
- 09 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 09 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 09 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 23 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Feb 2023 — NON-FINAL ACTION E-MAILED
- 23 Feb 2023 — NON-FINAL ACTION WRITTEN
- 21 Feb 2023 — ASSIGNED TO EXAMINER
- 07 May 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 May 2022 — NEW APPLICATION ENTERED